News
FDA clears first brain stimulation device to help smokers quit
- Author:
- Megan Brooks
The company plans a “controlled” U.S. market release of the system for this indication early next year.
News
COVID-19 linked to development of myasthenia gravis
- Author:
- Megan Brooks
Italian researchers report three cases of myasthenia gravis onset after COVID-19 infection.
News
Oleander extract for COVID-19? That’s a hard ‘no’ experts say
- Author:
- Megan Brooks
Oleandrin poisoning may affect the central nervous system, as evidenced by drowsiness, tremors, seizures, collapse, and coma leading to death.
News
CDC data confirm mental health is suffering during COVID-19
- Author:
- Megan Brooks
The prevalence of symptoms of anxiety disorder alone was roughly three times that reported in the second quarter of 2019.
News
FDA approves viltolarsen (Viltepso) for Duchenne muscular dystrophy
- Author:
- Megan Brooks
The approval marks the second drug therapy for Duchenne muscular dystrophy.
News
Experimental nonstimulant effective, fast-acting for ADHD
- Author:
- Megan Brooks
The fact that viloxazine was effective for both inattentive and hyperactive/impulsive clusters of symptoms is "impressive," study investigator Dr...
News
Vitamin D fails to prevent late-life depression, boost mood
- Author:
- Megan Brooks
"The study is among the largest of its kind ever," said Dr. Olivia Okereke, of Massachusetts General Hospital.
News
Cognitive impairment in 9/11 responders tied to brain atrophy
- Author:
- Megan Brooks
Neuroimaging suggests that a neurodegenerative condition may be present in first responders who experience cognitive impairment in midlife.
News
FDA okays new indication for esketamine nasal spray
- Author:
- Megan Brooks
“Esketamine may offer clinicians a new way to provide support to patients quickly in the midst of an urgent depressive episode,” said Dr. Gerard...
News
Global study to track COVID-19’s impact on the brain
- Author:
- Megan Brooks
The research will track and evaluate the short- and long-term impact of the coronavirus on the brain, including cognition, behavior, and function...
News
Infection ups mortality risk in patients with dementia
- Author:
- Megan Brooks
Those with dementia had a greater than sixfold increased risk of dying after acquiring any infection than those without dementia or an infection...
News
P-tau217 differentiates Alzheimer’s disease from other neurodegenerative conditions
- Author:
- Megan Brooks
Increasing blood P-tau217 levels can be detected in some individuals up to 20 years before the onset of cognitive decline.
News
Flu and pneumonia vaccination tied to lower dementia risk
- Author:
- Megan Brooks
These preliminary data suggest that vaccination against both respiratory illnesses may lower the risk for cognitive decline and dementia.
News
US News releases latest top hospitals list, adds COVID heroes
- Author:
- Megan Brooks
Our Hospital Heroes series is a tribute to recognizing individuals at urban and rural hospitals in communities across the country.
News
Levothyroxine: No LV benefit in subclinical hypothyroidism with MI
- Author:
- Megan Brooks
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not...